| 1 |
Srisuphanunt M, Wilairatana P, Kooltheat N, Duangchan T, Katzenmeier G, Rose JB. Molecular Mechanisms of Antibiotic Resistance and Novel Treatment Strategies for Helicobacter pylori Infections. TropicalMed 2023;8:163. [DOI: 10.3390/tropicalmed8030163] [Reference Citation Analysis]
|
| 2 |
Boyanova L, Hadzhiyski P, Gergova R, Markovska R. Evolution of Helicobacter pylori Resistance to Antibiotics: A Topic of Increasing Concern. Antibiotics (Basel) 2023;12. [PMID: 36830243 DOI: 10.3390/antibiotics12020332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Almashhadany DA, Mayas SM, Mohammed HI, Hassan AA, Khan IUH. Population- and Gender-Based Investigation for Prevalence of Helicobacter pylori in Dhamar, Yemen. Can J Gastroenterol Hepatol 2023;2023:3800810. [PMID: 36742348 DOI: 10.1155/2023/3800810] [Reference Citation Analysis]
|
| 4 |
Zhang Y, Feng X, Bian L, Zhang Y, Li Q, Xu Y, She Q, Yan C, Lu G, Wu J, Xiao W, Ding Y, Deng B. Antibiotic Resistance of Helicobacter pylori and Related Risk Factors in Yangzhou, China: A Cross-Sectional Study. J Clin Med 2023;12. [PMID: 36769465 DOI: 10.3390/jcm12030816] [Reference Citation Analysis]
|
| 5 |
Arif M, Ahmad R, Sharaf M, Samreen, Muhammad J, Abdalla M, Eltayb WA, Liu CG. Antibacterial and antibiofilm activity of mannose-modified chitosan/PMLA nanoparticles against multidrug-resistant Helicobacter pylori. Int J Biol Macromol 2022;223:418-32. [PMID: 36356866 DOI: 10.1016/j.ijbiomac.2022.10.265] [Reference Citation Analysis]
|
| 6 |
Shao Y, Lin Y, Wang B, Miao M, Ye G. Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021. Helicobacter 2022;27:e12920. [PMID: 35939548 DOI: 10.1111/hel.12920] [Reference Citation Analysis]
|
| 7 |
Chen J, Li P, Huang Y, Guo Y, Ding Z, Lu H. Primary Antibiotic Resistance of Helicobacter pylori in Different Regions of China: A Systematic Review and Meta-Analysis. Pathogens 2022;11:786. [DOI: 10.3390/pathogens11070786] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 8 |
Saha K, Sarkar D, Khan U, Karmakar BC, Paul S, Mukhopadhyay AK, Dutta S, Bhattacharya S. Capsaicin Inhibits Inflammation and Gastric Damage during H pylori Infection by Targeting NF-kB–miRNA Axis. Pathogens 2022;11:641. [DOI: 10.3390/pathogens11060641] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Ejaz S, Ejaz S, Shahid R, Noor T, Shabbir S, Imran M. Chitosan-curcumin complexation to develop functionalized nanosystems with enhanced antimicrobial activity against hetero-resistant gastric pathogen. Int J Biol Macromol 2022;204:540-54. [PMID: 35157901 DOI: 10.1016/j.ijbiomac.2022.02.039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Syahniar R, Swasti Kharisma D, Rayhana. Helicobacter pylori Challenge Vaccine for Humans. Vaccine Development 2022. [DOI: 10.5772/intechopen.101157] [Reference Citation Analysis]
|
| 11 |
Sampath G, Govarthanan M, K S, N P, Rameshkumar N, Krishnan M, Nagarajan K. Isolation and identification of metronidazole resistance Helicobacter pylori from gastric patients in the southeastern region of India and its advanced antibacterial treatment using biological silver oxide nanoparticles. Biochemical Engineering Journal 2022. [DOI: 10.1016/j.bej.2022.108445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Dai J, Zhao J, Mao L, Hu Y, Lv B. Study on the value of antibiotic-resistant gene detection in Helicobacter pylori in China. Exp Ther Med 2022;23:228. [PMID: 35222705 DOI: 10.3892/etm.2022.11153] [Reference Citation Analysis]
|
| 13 |
Brincat A, Hofmann M. Automated extraction of genes associated with antibiotic resistance from the biomedical literature. Database 2022;2022. [DOI: 10.1093/database/baab077] [Reference Citation Analysis]
|
| 14 |
Lee S, Alishir A, Kim TW, Kang D, Ryoo R, Pang C, Ahn M, Kim KH. First Chemical Investigation of Korean Wild Mushroom, Amanita hemibapha subsp. javanica and the Identification of Anti-Helicobacter pylori Compounds. Pharmaceuticals 2022;15:152. [DOI: 10.3390/ph15020152] [Reference Citation Analysis]
|
| 15 |
Lormohammadi L, Nikkhahi F, Bolori S, Karami AA, Hajian S, Rad N, Peymani A, Samimi R. High level of resistance to metronidazole and clarithromycin among Helicobacter pylori clinical isolates in Qazvin province, Iran. Gene Reports 2022. [DOI: 10.1016/j.genrep.2022.101494] [Reference Citation Analysis]
|
| 16 |
Nayim P, Mbaveng AT, Kuete V. Anti-Helicobacter pylori activities of African medicinal plants. Advances in Botanical Research 2022. [DOI: 10.1016/bs.abr.2022.08.010] [Reference Citation Analysis]
|
| 17 |
Hussein RA, Al-Ouqaili MTS, Majeed YH. Detection of clarithromycin resistance and 23SrRNA point mutations in clinical isolates of Helicobacter pylori isolates: Phenotypic and molecular methods. Saudi J Biol Sci 2022;29:513-20. [PMID: 35002447 DOI: 10.1016/j.sjbs.2021.09.024] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Ru C, Yin L, Tian L, Wang L, Yao Y, Kang L, Li J. Correlation Analysis between the Characteristics of Helicobacter pylori Resistance and the Antibiotic Use Density in a Hospital from 2012 to 2018. J Healthc Eng 2021;2021:5031667. [PMID: 34804452 DOI: 10.1155/2021/5031667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 19 |
Hosseini RS, Rahimian G, Shafigh MH, Validi M, Khaledi M, Gholipour A. Correlation between clarithromycin resistance, virulence factors and clinical characteristics of the disease in Helicobacter pylori infected patients in Shahrekord, Southwest Iran. AMB Express 2021;11:147. [PMID: 34731345 DOI: 10.1186/s13568-021-01310-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 20 |
Seyedmajidi MR, Hosseini SA, Vafaeimanesh J. Comparing the Effect of Two Low-dose and High-dose Four-drug Regimens of Furazolidone in Eradicating Helicobacter Pylori. Middle East J Dig Dis 2021;13:131-8. [PMID: 34712451 DOI: 10.34172/mejdd.2021.216] [Reference Citation Analysis]
|
| 21 |
Li B, Su Y, Xiang N, Qin B, Li G, Wan T, Liu X, Wang D, Jiang C, Wen L, Feng QS. Comparative serum microRNA array analysis of the spleen-stomach dampness-heat syndrome in different diseases: Chronic hepatitis B and chronic gastritis. Anat Rec (Hoboken) 2021;304:2620-31. [PMID: 34288535 DOI: 10.1002/ar.24690] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 22 |
Lee L, Samardzic K, Wallach M, Frumkin LR, Mochly-Rosen D. Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases. Front Immunol 2021;12:696003. [PMID: 34177963 DOI: 10.3389/fimmu.2021.696003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 23 |
Mi M, Wu F, Zhu J, Liu F, Cui G, Wen X, Hu Y, Deng Z, Wu X, Zhang Z, Qi T, Chen Z. Heterogeneity of Helicobacter pylori Strains Isolated from Patients with Gastric Disorders in Guiyang, China. Infect Drug Resist 2021;14:535-45. [PMID: 33603417 DOI: 10.2147/IDR.S287631] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 24 |
Albasha AM, Elnosh MM, Osman EH, Zeinalabdin DM, Fadl AAM, Ali MA, Altayb HN. Helicobacter pylori 23S rRNA gene A2142G, A2143G, T2182C, and C2195T mutations associated with clarithromycin resistance detected in Sudanese patients. BMC Microbiol 2021;21:38. [PMID: 33535966 DOI: 10.1186/s12866-021-02096-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 25 |
Al-khafaji ZM, Mahmood AB, Mahmood MB. Food constituents for inhibition of BabA of Helicobacter pylori. J Drug Delivery Ther 2020;10:152-163. [DOI: 10.22270/jddt.v10i5-s.4358] [Reference Citation Analysis]
|
| 26 |
Atehortua Rendon JD, Pérez Cala TL, Martínez A. Descripción de la resistencia de Helicobacter pylori a seis antibióticos de uso frecuente en Colombia. Rev Colomb Gastroenterol 2020;35:351-361. [DOI: 10.22516/25007440.493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 27 |
O'Connor A, Furuta T, Gisbert JP, O'Morain C. Review - Treatment of Helicobacter pylori infection 2020. Helicobacter 2020;25 Suppl 1:e12743. [PMID: 32918350 DOI: 10.1111/hel.12743] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 28 |
Garvey M. Bacteriophages and the One Health Approach to Combat Multidrug Resistance: Is This the Way? Antibiotics (Basel) 2020;9:E414. [PMID: 32708627 DOI: 10.3390/antibiotics9070414] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 29 |
Azzaya D, Gantuya B, Oyuntsetseg K, Davaadorj D, Matsumoto T, Akada J, Yamaoka Y. High Antibiotic Resistance of Helicobacter pylori and Its Associated Novel Gene Mutations among the Mongolian Population. Microorganisms 2020;8:E1062. [PMID: 32708761 DOI: 10.3390/microorganisms8071062] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 30 |
Parra-Sepúlveda C, Merino JS, Sáez-Carrillo K, González C, García-Cancino A. ANTIBIOTIC RESISTANCE SURVEILLANCE OF HELICOBACTER PYLORI AT THE BIOBÍO REGION (CHILE) IN A DECADE. Arq Gastroenterol 2019;56:361-6. [PMID: 31721972 DOI: 10.1590/S0004-2803.201900000-72] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 31 |
Chu A, Wang D, Guo Q, Lv Z, Yuan Y, Gong Y. Molecular detection of H. pylori antibiotic‐resistant genes and molecular docking analysis. FASEB j 2020;34:610-8. [DOI: 10.1096/fj.201900774r] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 32 |
Oporto M, Pavez M, Troncoso C, Cerda A, Hofmann E, Sierralta A, Rios E, Coppelli L, Barrientos L. Prevalence of Infection and Antibiotic Susceptibility of Helicobacter pylori: An Evaluation in Public and Private Health Systems of Southern Chile. Pathogens 2019;8:E226. [PMID: 31717523 DOI: 10.3390/pathogens8040226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
